David J. Matlin, an investor managing his personal assets, has filed the Fourth Amended and Restated Schedule 13D with the SEC, indicating a significant increase in his stake in Clene Inc. As of September 30, 2024, Matlin's beneficial ownership in Clene Inc. amounts to 718,196 shares, representing 8.7% of the company's outstanding common stock. This position includes 23,897 shares issuable upon the exercise of options and 242,307 shares issuable upon the exercise of warrants, both currently exercisable or exercisable within 60 days. The filing, dated October 2, 2024, reflects a recent purchase of 92,307 shares of Clene Inc.'s common stock and an equal number of warrants with an exercise price of $4.82 per share, totaling approximately $450,000 from personal funds. Matlin, who also serves as the Chairman of the Board of Directors of Clene Inc., has expressed his belief in the attractiveness of the company's securities at current market prices and may consider increasing his position depending on market conditions and stock availability. The filing updates previous amendments and restatements dating back to the original Schedule 13D filed on February 6, 2023.

David J. Matlin, an investor managing his personal assets, has filed the Fourth Amended and Restated Schedule 13D with the SEC, indicating a significant increase in his stake in Clene Inc. As of September 30, 2024, Matlin's beneficial ownership in Clene Inc. amounts to 718,196 shares, representing 8.7% of the company's outstanding common stock. This position includes 23,897 shares issuable upon the exercise of options and 242,307 shares issuable upon the exercise of warrants, both currently exercisable or exercisable within 60 days. The filing, dated October 2, 2024, reflects a recent purchase of 92,307 shares of Clene Inc.'s common stock and an equal number of warrants with an exercise price of $4.82 per share, totaling approximately $450,000 from personal funds. Matlin, who also serves as the Chairman of the Board of Directors of Clene Inc., has expressed his belief in the attractiveness of the company's securities at current market prices and may consider increasing his position depending on market conditions and stock availability. The filing updates previous amendments and restatements dating back to the original Schedule 13D filed on February 6, 2023.